Miyata T, Oda O, Inagi R, et al.: beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. In: J. Clin. Invest. 92. Jahrgang, Nr.3, September 1993, S.1243–52, doi:10.1172/JCI116696, PMID 8376584, PMC 288264 (freier Volltext).
nih.gov
ncbi.nlm.nih.gov
Miyata T, Oda O, Inagi R, et al.: beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. In: J. Clin. Invest. 92. Jahrgang, Nr.3, September 1993, S.1243–52, doi:10.1172/JCI116696, PMID 8376584, PMC 288264 (freier Volltext).